Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_assertion type Assertion NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_head.
- NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_assertion description "[In patients with MM sAng-2 levels were significantly increased with increasing stage of disease, from stage I to stage III (P < 0.03) and presented a trend of correlation with Beta2-microglobulin levels (r = 0.317) and grade of bone involvement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_provenance.
- NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_assertion evidence source_evidence_literature NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_provenance.
- NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_assertion SIO_000772 16978237 NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_provenance.
- NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_assertion wasDerivedFrom befree-20140225 NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_provenance.
- NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_assertion wasGeneratedBy ECO_0000203 NP727743.RArRRJpMhF5aoiTJsNtdn6wPVodtf99sGrDSdUS1axL3A130_provenance.